mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.01 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
Roscovitine |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |